4//SEC Filing
Conway Kevin John 4
Accession 0001415889-25-010856
CIK 0001733294other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:05 PM ET
Size
8.6 KB
Accession
0001415889-25-010856
Insider Transaction Report
Form 4
Conway Kevin John
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2025-04-15$0.37/sh−173$64→ 17,859 total - Exercise/Conversion
Common Stock
2025-04-15+587→ 18,032 total - Exercise/Conversion
Restricted Stock Units
2025-04-15−587→ 4,107 total→ Common Stock (587 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F2]The grant of 9,390 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0002051408
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:05 PM ET
- Size
- 8.6 KB